Group 1 - Wantaibio (603392.SH) reported its Q3 2025 results, with 12 institutional investors holding a total of 731 million shares, representing 57.77% of the total share capital [1] - The top ten institutional investors include major entities such as YS Health, Hong Kong Central Clearing, and various index funds, collectively holding 57.76% of shares, a decrease of 2.67 percentage points from the previous quarter [1] Group 2 - In the public fund sector, four funds increased their holdings, including Huaxia National Bio-Medical Index Fund and others, with a slight increase in holding percentage [2] - Five public funds reduced their holdings, with a total decrease of 0.10%, including funds like China National Bio-Medical Index A and others [2] - One new public fund was disclosed this period, while 253 funds were not disclosed compared to the previous quarter, indicating significant turnover in fund disclosures [2]

Group 1 - Lijun Group (000513.SZ) reported its 2025 semi-annual results, with 39 institutional investors holding a total of 303 million shares, representing 33.47% of the total share capital [1] - The top ten institutional investors collectively hold 33.12% of the shares, a decrease of 1.85 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, seven funds increased their holdings, including Southern CSI 500 ETF and Huaxia National Vaccine and Biotechnology Index Fund A, while three funds reduced their holdings [2] - A total of 20 new public funds disclosed their holdings this period, with notable mentions including China Europe Medical Health Mixed Fund A and Guotai Health Stock A [2] - One social security fund increased its holdings, while one was no longer disclosed [2] - One insurance fund reduced its holdings, specifically Ruizhong Life Insurance's proprietary funds [2] Group 3 - Foreign investment sentiment showed a decrease in holdings from one foreign fund, Hong Kong Central Clearing Limited, with a reduction of 1.33% [3] - One foreign institution, the Macao Financial Management Bureau, was no longer disclosed this period [3]